ASTELLAS PHARMA INC. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,556 JPY | -0.13% |
|
+2.74% | -7.74% |
| 05-02 | Poseida Therapeutics to Receive Up to $600 Million in Cancer Gene Therapy Research, Development Deal With Xyphos | MT |
| 05-01 | Malin Corp investee signs agreement with Astellas Pharma | AN |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ASTELLAS PHARMA INC. | Other Pharmaceuticals | -0.13% | +2.74% | -7.74% | -24.82% | +4.75% | 18.14B |  | | |
Technical Rankings Surperformance
- Stock Market
- Equities
- 4503 Stock
- Charts Astellas Pharma Inc.
- Comparison Chart